CN102215835A - 一种医药产品及其治疗领域 - Google Patents

一种医药产品及其治疗领域 Download PDF

Info

Publication number
CN102215835A
CN102215835A CN2009801365433A CN200980136543A CN102215835A CN 102215835 A CN102215835 A CN 102215835A CN 2009801365433 A CN2009801365433 A CN 2009801365433A CN 200980136543 A CN200980136543 A CN 200980136543A CN 102215835 A CN102215835 A CN 102215835A
Authority
CN
China
Prior art keywords
ibuprofen
paracetamol
moderate
treatment
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2009801365433A
Other languages
English (en)
Chinese (zh)
Inventor
哈特利·坎贝尔·阿特金森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AFT Pharmaceuticals Ltd
Original Assignee
AFT Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42106693&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN102215835(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by AFT Pharmaceuticals Ltd filed Critical AFT Pharmaceuticals Ltd
Publication of CN102215835A publication Critical patent/CN102215835A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
CN2009801365433A 2008-10-14 2009-10-12 一种医药产品及其治疗领域 Pending CN102215835A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ56961208 2008-10-14
NZ569612 2008-10-14
PCT/NZ2009/000220 WO2010044681A1 (en) 2008-10-14 2009-10-12 A medicinal product and treatment

Publications (1)

Publication Number Publication Date
CN102215835A true CN102215835A (zh) 2011-10-12

Family

ID=42106693

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009801365433A Pending CN102215835A (zh) 2008-10-14 2009-10-12 一种医药产品及其治疗领域

Country Status (29)

Country Link
US (1) US20110166234A1 (enExample)
EP (1) EP2341900B1 (enExample)
JP (1) JP2012505830A (enExample)
KR (1) KR20110112279A (enExample)
CN (1) CN102215835A (enExample)
AU (1) AU2009304002B9 (enExample)
BR (1) BRPI0914086A2 (enExample)
CA (1) CA2735834C (enExample)
CH (1) CH702339B1 (enExample)
CL (1) CL2011000678A1 (enExample)
CO (1) CO6341553A2 (enExample)
CY (1) CY1122198T1 (enExample)
DK (1) DK2341900T3 (enExample)
ES (1) ES2725151T3 (enExample)
GB (1) GB2476418B (enExample)
HR (1) HRP20190891T1 (enExample)
HU (1) HUE043063T2 (enExample)
LT (1) LT2341900T (enExample)
MA (1) MA32635B1 (enExample)
MX (1) MX340662B (enExample)
MY (1) MY153932A (enExample)
NZ (1) NZ591496A (enExample)
PL (1) PL2341900T3 (enExample)
PT (1) PT2341900T (enExample)
RU (1) RU2487707C2 (enExample)
SI (1) SI2341900T1 (enExample)
TR (2) TR201906742T4 (enExample)
WO (1) WO2010044681A1 (enExample)
ZA (1) ZA201101752B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0512756A (pt) 2004-07-07 2008-04-08 Aft Pharmaceuticals Ltd composição farmacêutica de combinação para o tratamento de dor, método de controle de dor, uso de uma composição e embalagem farmacêutica incluindo comprimidos ou cápsulas
ES2742373T3 (es) * 2010-11-04 2020-02-14 Aft Pharmaceuticals Ltd Una composición de combinación
WO2016008546A1 (en) 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
WO2018192664A1 (en) 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF
EP4480495A3 (en) * 2017-07-10 2025-06-18 Gel Cap Technologies, LLC Dual release dosage form capsule and methods, devices and systems for making same
US11197830B2 (en) 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
WO2023281089A2 (en) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Pharmaceutical composition comprising naproxen and paracetamol

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0109281A1 (en) * 1982-11-15 1984-05-23 The Upjohn Company Compositions comprising flurbiprofen or ibuprofen
ZA837556B (en) * 1982-11-15 1984-06-27 Upjohn Co Acetominophen and ibuprofen/flurbiprofen
AU605538B2 (en) * 1988-01-19 1991-01-17 Adcock Ingram Limited Pharmaceutical unit
CA1336687C (en) * 1989-08-23 1995-08-15 Thomas M. Tencza Process for preparing tablets containing ibuprofen, apap and caffeine, the products of this process and the use of such products
BRPI0512756A (pt) 2004-07-07 2008-04-08 Aft Pharmaceuticals Ltd composição farmacêutica de combinação para o tratamento de dor, método de controle de dor, uso de uma composição e embalagem farmacêutica incluindo comprimidos ou cápsulas
GB0519350D0 (en) * 2005-09-22 2005-11-02 Boots Healthcare Int Ltd Therapeutic agents
US20090264530A1 (en) * 2008-04-16 2009-10-22 Nickell Robert P Combined nsaid and acetaminophen formulation and method

Also Published As

Publication number Publication date
AU2009304002B2 (en) 2013-04-18
CH702339B1 (de) 2016-06-15
AU2009304002B9 (en) 2014-06-26
MY153932A (en) 2015-04-15
KR20110112279A (ko) 2011-10-12
SI2341900T1 (sl) 2019-06-28
LT2341900T (lt) 2019-04-10
HRP20190891T1 (hr) 2019-07-12
CA2735834C (en) 2017-05-16
EP2341900A1 (en) 2011-07-13
ES2725151T3 (es) 2019-09-19
JP2012505830A (ja) 2012-03-08
GB2476418A (en) 2011-06-22
CO6341553A2 (es) 2011-11-21
HUE043063T2 (hu) 2019-07-29
TR201906742T4 (tr) 2019-05-21
NZ591496A (en) 2012-12-21
PL2341900T3 (pl) 2019-08-30
TR201102810T2 (tr) 2011-05-23
MX2011003928A (es) 2011-08-12
WO2010044681A1 (en) 2010-04-22
CY1122198T1 (el) 2020-11-25
AU2009304002A1 (en) 2010-04-22
MA32635B1 (fr) 2011-09-01
GB201105249D0 (en) 2011-05-11
CA2735834A1 (en) 2010-04-22
RU2011111792A (ru) 2012-11-27
RU2487707C2 (ru) 2013-07-20
BRPI0914086A2 (pt) 2020-01-21
MX340662B (es) 2016-07-20
ZA201101752B (en) 2012-02-29
DK2341900T3 (da) 2019-05-20
US20110166234A1 (en) 2011-07-07
CL2011000678A1 (es) 2011-09-23
PT2341900T (pt) 2019-05-14
EP2341900A4 (en) 2012-02-29
GB2476418B (en) 2013-04-24
EP2341900B1 (en) 2019-02-20

Similar Documents

Publication Publication Date Title
Yousef et al. A double‐blinded randomised controlled study of the value of sequential intravenous and oral magnesium therapy in patients with chronic low back pain with a neuropathic component
JP2007302657A (ja) 痙症の兆候および症候の緩和方法
US20100226972A1 (en) Transdermal pain gel
MX2013005113A (es) Una composicion combinada.
EP2341900B1 (en) A medicinal product and treatment
CA2570474A1 (en) A combination composition comprising paracetamol and ibuprofen
US11033521B2 (en) Levodopa fractionated dose composition and use
US20220193091A1 (en) Combined administration of diazepam and diclofenac for the treatment of pain
CN102228466A (zh) 硫酸软骨素氨糖片
US20140037718A1 (en) Transdermal pain gel
JP2014530249A5 (enExample)
US9415064B2 (en) Prevention or treatment of painful polyneuropathies by administration of an aluminosilicate
CA2840521C (en) Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation
CN104906501A (zh) 治疗银屑病的中药组分组合物
JP4553552B2 (ja) 生体リズム応用キット
MX2015003879A (es) Metodos para aliviar sintomas de esclerosis multiple basados en composiciones que contienen apoaecuorina.
CN108371712B (zh) 咖啡因与PPARγ激动剂联合制备AD药物中的用途
Zhang et al. Preparation and pre-clinical characterization of sustained-release ketoprofen implants for the management of pain and inflammation in osteoarthritis
Priyanka Efficacy of Preemptive Oral Pregabalin in Reduction of Acute Postoperative Pain in Patients Undergoing Total Knee Arthroplasty in a Tertiary Care Hospital in Chengalpattu District: A Double Blind Randomised Controlled Trial.
CN103315989B (zh) 一种药物组合物
CN103301124B (zh) 一种治疗癫痫的药物组合物
Kamhawy et al. Dexmedetomidine as an adjuvant to bupivacaine on combined posterior lumbar plexus and sciatic nerve blocks, is it effective?
Wright et al. Pain CHAPTER and analgesia
CN102008722A (zh) 一种治疗偏头痛的奈普生及曲坦类药物复方制剂
Gilhooly Low-dose naltrexone as a treatment for multiple sclerosis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20111012